DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Yun J, Lee SH, Kim SY. et al.
Antitumor activity of amivantamab (JNJ-61186372), an EGFR-MET bispecific antibody, in diverse models of EGFR Exon 20 insertion-driven NSCLC.
Cancer Discov 2020;
10 (08) 1194-1209
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.